Table 5.
Test | Definition | Participants tested N |
Follow-up years Median (IQR) |
Clinical finding* N |
|
Coronary calcification |
|
12 846 | 5.6 (3.2–8.0) | 805 | |
Atrial fibrillation |
|
91 076 | 4.1 (2.1–6.5) | 446 | |
Left bundle branch block |
|
91 076 | 4.1 (2.1–6.5) | 64 | |
Chronic kidney disease |
|
91 197 | 4.0 (2.1–6.5) | 5372 | |
Visceral obesity |
|
34 771 | 5.0 (3.0–7.4) | 23 126 | |
Fatty liver |
|
34 771 | 5.0 (3.0–7.4) | Mild | 10 244 |
Moderate | 5963 | ||||
Severe | 688 | ||||
Abnormal thyroid function |
|
77 313 | 4.1 (2.2–6.6) | Hypothyroidism | 363 |
Hyperthyroidism | 1260 | ||||
Helicobacter pylori infection |
|
81 142 | 4.2 (2.3–6.7) | 44 304 | |
High-risk HPV infection |
|
12 999 | 5.0 (3.1–7.2) | 1462 | |
Parasite infection |
|
82 493 | 4.1 (2.2–6.6) | Clonorchis sinensis | 1262 |
Ascaris lumbricoides | 124 | ||||
Trichuris trichiura | 256 | ||||
Metagonimus yokogawai | 412 | ||||
Premalignant conditions of stomach |
|
66 451 | 4.2 (2.3–6.7) | Atrophic gastritis | 23 896 |
Intestinal metaplasia | 10 187 | ||||
Malignant gastric cancer |
|
66 451 | 4.2 (2.3–6.7) | 299 | |
SIL |
|
12 951 | 5.0 (3.1–7.2) | Total SIL | 375 |
Low grade | 315 | ||||
High grade | 60 | ||||
Premalignant colonic neoplasms |
|
46 746 | 4.8 (2.9–7.1) | Adenoma | 18 656‡ |
Serrated polyp | 1178‡ | ||||
Carcinoid | 150 | ||||
Malignant colon cancer |
|
46 746 | 4.8 (2.9–7.1) | 262 | |
Low bone density |
|
35 695 | 4.8 (2.9–7.2) | Osteopenia Male Female |
2322 8279 |
Osteoporosis Male Female |
305 1348 |
||||
Periodontitis |
|
43 232 | 4.9 (2.8–7.2) | Total periodontitis | 15 204 |
Mild to moderate | 14 292 | ||||
Severe | 912 |
*The number of findings among the participants who were at risk.
†The GFR was estimated by the Chronic Kidney Disease Epidemiology Collaboration equation and the Modification of Diet in Renal Disease formula.
‡Adenoma and serrated polyp detection rate were calculated in participants aged 50–75 years.
CLO, Campylobacter-like organism; GFR, glomerular filtration rate; HPV, human papillomavirus; SIL, squamous intraepithelial lesion; UBT, urea breath test.